Loading...
CRMD logo

CorMedix Community

NasdaqGM:CRMD Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 63 Fair Values set on narratives written by author

Community Investing Ideas

CRMD logo
CorMedix

Acquisition And Pipeline Expansion Will Unlock Healthcare Potential

Key Takeaways Acquisition and integration efforts diversify revenue streams and improve operational efficiency, supporting stronger earnings and margin growth. Expanded pipeline and portfolio address rising demand in infection control, enhancing market penetration and supporting long-term profitability.

View narrative
0users have liked this narrative
0users have commented on this narrative
27users have followed this narrative
US$20.4
45.2% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
52.83% p.a.
Profit Margin
56.43%
Future PE
9.24x
Share price in 2028
US$16.26